
Wall Street's Trump TACO trade has a chicken and an egg problem
President Donald Trump is once more threatening to lob massive duties on a wide swath of US imports, everything from copper and pharmaceuticals to goods from Japan and Russia.
Yet Wall Street is barely flinching, with some investors betting Trump will repeat his tendency to back down from his most extreme threats.
The muted response is just the latest instance of what's known as the TACO trade, short for Trump Always Chickens Out.
'He steers us toward disaster and then — at the last minute — steers us away from disaster and says, 'Look, I saved us,'' Michael Block, market strategist at Third Seven Capital, told CNN in a phone interview on Tuesday.
That's what happened in early April. Trump announced sky-high 'Liberation Day' tariffs that alarmed investors, convincing many that a recession was imminent.
The market freakout — both in stocks and bonds — was so intense that it convinced Trump to back down. He abruptly froze those 'reciprocal' tariffs for 90 days, setting off an epic market recovery that continues today.
Flash forward to this week's 'Liberation Day' sequel. US stocks retreated on Monday after Trump sent letters to Japan, South Korea and a dozen other nations dictating tariffs to take effect on August 1.
But the selling wasn't dramatic. It was a modest (and arguably overdue) pullback from all-time highs.
Markets barely budged at all on Tuesday as Trump vowed to put a 50% tariff on copper, floated a tariff of up to 200% on pharmaceuticals and promised a 10% tariff on Brazil, China, India, Russia and other members of the BRICS economic club.
'At the end of the day, no one really anticipates most of these tariffs will go into effect. The TACO trade is still the market's expectations,' said Ed Mills, Washington policy analyst at Raymond James.
Yet there could be a flaw in Wall Street's TACO trade logic.
If investors widely bet that Trump will blink, that means there is no market freakout. And no market freakout in turn means no one is holding Trump's feet to the fire, pressuring him to back away from policies that could damage the economy and corporate profits.
'It's a dangerous game when you need a market reaction to get a policy change,' Mills said.
It's the market version of a chicken and egg problem.
Bob Elliott, CEO of alternative investment firm Unlimited, noted on X that TACO is 'consensus and already fully priced in at these levels.'
'Trouble is, without the pain of falling markets, he won't chicken out,' said Elliott, a former executive at hedge fund giant Bridgewater Associates.
The paradox is complicated even further by the fact that Trump himself is aware of the TACO trade.
When first asked about TACO, in late May, Trump recoiled and described it as the 'nastiest question' and told the reporter not to 'ever say what you said.'
'I chicken out? Oh, I've never heard that,' Trump said at the time.
Then after investors seemed unfazed by the Monday tariff letters, Trump posted a message insisting he won't chicken out this time.
'TARIFFS WILL START BEING PAID ON AUGUST 1, 2025,' Trump wrote on Truth Social. 'No extensions will be granted.'
But investors aren't buying it.
No extensions — 'until further notice,' Ed Yardeni, president of Yardeni Research, said to CNN.
Yardeni said there is 'far less panic' in markets today than in early April because investors are betting Trump doesn't want to sink the US economy and hurt his own political standing.
'The market figures this is the art of the deal. While there is a lot of bluster here, this is the way Trump negotiates,' Yardeni said. 'Trump is going to have to put this issue behind him by the end of the summer or early fall because he's risking causing a recession that would diminish the odds that Republicans hold onto their thin majorities in the Senate and the House.'
Of course, there is a risk that without an outcry from Wall Street, and emboldened by mostly upbeat economic numbers, Trump goes forward with the same tariffs investors are betting against.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 minutes ago
- Yahoo
Brachytherapy Devices Market is Growing at CAGR of 6.7% During 2025 -2031 to Reach US$534.20 Million
NEW YORK, Aug 4, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the Brachytherapy Devices Market is witnessing significant growth due to the rising incidence of cancer worldwide and technological advancements in brachytherapy devices. The Brachytherapy Devices Market value is expected to reach US$534.20 million by 2031 from US$343.57 million in 2024; the market is anticipated to register a CAGR of 6.7% during 2025–2031. The market growth is attributed to the rising incidence of cancer worldwide, the aging population, and the technological advancements in brachytherapy devices. The Brachytherapy Devices Market analysis focuses on advancements such as MRI-compatible applicators and real-time imaging integration that play a vital role in the market growth. The report runs an in-depth analysis of market trends, key players, and future opportunities. Check valuable insights in the Brachytherapy Devices Market report. You can easily get a sample PDF of the report - Overview of Brachytherapy Devices Market Report Findings Rising Incidence of Cancer Worldwide:As per the GLOBOCAN 2020 report, more than 28.4 million new cancer cases are expected to be reported by 2040. An aging population, lack of physical activity, exposure to pollutants in the environment, and alterations in diet lead to increased rates of an internal radiation treatment, is ideal for the treatment of prostate, cervical, breast, and skin cancers. It allows for the radiation to be targeted directly to the tumor and avoid the surrounding healthy tissues, with reduced side effects and improved recovery times. Thus, brachytherapy is becoming increasingly popular among oncologists and cancer remains among the major causes of mortality globally, demand for effective, low-invasive, and affordable treatment procedures is rising. Brachytherapy is meeting this demand, particularly in facilities where it might not be possible to access highly advanced external radiation facilities. Thus, the increasing burden of cancers worldwide propels the market growth. Technological Advancements in Brachytherapy Devices:Advances in the area are improving the accuracy, safety, and effectiveness of treatments, making brachytherapy a progressively appealing choice for cancer technological advancements include the creation of high-dose rate (HDR) and low-dose rate (LDR) machines, which provide more accurate radiation delivery. HDR machines provide for administering higher doses of radiation in shorter times, making treatment faster and more convenient for patients. MRI-compatible applicators and integration of sophisticated imaging are providing better tumor localization and online monitoring of treatment. These advances allow clinicians to target tumors effectively with less exposure to healthy tissues in the proximity. The robot-assisted platforms provide higher accuracy and precision, particularly in challenging anatomical areas. In addition, miniaturization and mobility of brachytherapy equipment are facilitating treatments, especially in developing advances in technology are making brachytherapy more effective and safer but and increasing its uses in treating a broader spectrum of cancers. Consequently, the greater uptake of these machines is contributing to their adoption and setting the limits of cancer treatment even higher. Geographical Insights: In 2024, North America led the market with a substantial revenue share, followed by Europe and Asia Pacific. Asia Pacific is expected to register the highest CAGR during the forecast period. Stay Updated on Brachytherapy Devices Market Trends: Brachytherapy Devices Market Segmentation Based on product, the Brachytherapy Devices Market is segmented into seeds, brachytherapy afterloaders and applicators, and electronic brachytherapy. The brachytherapy afterloaders segment held the largest market share in 2024. In terms of type, the Brachytherapy Devices Market is categorized into high-dose rate brachytherapy implant and low-dose rate brachytherapy implant. The low-dose rate brachytherapy implant segment dominated the market in 2024. By application, the Brachytherapy Devices Market is segmented into breast cancer, cervical cancer, prostate cancer, lung cancer, and others. The prostate cancer segment dominated the market in 2024. Per end user, the Brachytherapy Devices Market is divided into hospitals and specialty clinics, ambulatory surgical centers, and others. The hospitals and specialty clinics segment dominated the market in 2024. The Brachytherapy Devices Market is segmented into five major regions: North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. Competitive Strategy and Development Key players: Elekta, Varian Medical Systems, Inc., BEBIG Medical, Theragenics Corporation, IsoAid, Siemens Healthineers AG, BXTA, BD, and Eckert and Ziegler are among the major companies operating in the Brachytherapy Devices Market. Trending topics: Advancements in Imaging Technologies, Government Initiatives and Cancer Treatment Programs, Technological Advancements in Brachytherapy Devices, Integration of Artificial Intelligence (AI) and Robotics in brachytherapy, etc. Headlines on Brachytherapy Devices Market Artemis Hospital Announces the Launch of Brachytherapy Services, Expanding Advanced Cancer Care Papua New Guinea Resumes Radiotherapy, Starts Brachytherapy Services with IAEA Support BEBIG Medical Launches SagiNova Brachytherapy System at Father Muller Hospital as a Part of New Healthcare Wing Medanta Patents MAOLO Brachytherapy Device For Advanced Cervical Cancer Treatment Elekta Expands Brachytherapy Portfolio With Acquisition of iCad Inc.'s Xoft Business CivaTech Oncology Receives FDA Approval for CivaSheet Brachytherapy Device Get Premium Copy of Brachytherapy Devices Market Size and Growth Report by 2031 at: Conclusion The growth of the Brachytherapy Devices Market is fueled by the increasing prevalence of cancer, advances in technology, and soaring demand for minimally invasive treatment options. The high-dose rate (HDR) systems, MRI-compatible applicators, and robotic-assisted devices are increasing the accuracy of treatment and speeding up patient recovery. Further, there is a growing demand for affordable and patient-centric therapies, particularly in areas that have poor access to conventional cancer therapy. With increasing uses in prostate, breast, and cervical cancers, the demand for brachytherapy is surging, with better results and accessibility in cancer therapy. The report from The Insight Partners provides several stakeholders—including manufacturers of seeds, brachytherapy afterloaders and applicators, and electronic brachytherapy devices—with valuable insights to navigate this evolving market landscape and unlock new opportunities. Trending Related Reports: Brachytherapy After Loaders Market Strategies, Top Players, Growth Opportunities, Analysis and Forecast by 2031 Cancer Therapy Market Scope, Share, and Size by 2031 Pancreatic Cancer Therapy Market SWOT Analysis by 2031 Lung Cancer Therapy Market Research Report by 2030 Cancer Biopsies Market Trends, Share, and Growth – 2031 Cervical Cancer Diagnostics and Therapeutics Market Size 2031 Kidney Cancer Therapeutics And Diagnostics Market Size 2031 Cancer Biopsies Market Trends, Share, and Growth - 2031 Thyroid Cancer Diagnostics Market Growth and Share by 2031 About Us: The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Contact Us:If you have any queries about this report or if you would like further information, please get in touch with us:Contact Person: Ankit MathurE-mail: +1-646-491-9876 Logo: View original content: SOURCE The Insight Partners Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
5 minutes ago
- Yahoo
Michigan State football loses recruiting staff member to Nevada
A familiar face in the recruiting department has departed Michigan State for a new position in the college football world. Austin D'Armond has left his role with Michigan State to become the Director of Player Personnel & Recruiting Strategy at Nevada. During his time at MSU, he held the role of Director of Player Personnel/Defense working on the Spartans recruiting efforts on the defensive side of the ball. Prior to joining Jonathan Smith and company in East Lansing, D'Armond was a member of Smith's staff in Corvallis at Oregon State for two seasons in a similar recruiting role. Getting an undergraduate and graduate degrees from Texas, D'Armond spent two years as a recruiting intern, and upon graduating, he became a player personnel graduate assistant for the Longhorns. Michigan State has already filled some of the void he left, adding Michael Morales from Texas to the staff, and there is an expectation that the Spartans could be making one or two more hires in it's recruiting department, that is led by Director of Recruiting and Player Relations, Michael Doctor. Contact/Follow us @The SpartansWire on X (formerly Twitter) and like our page on Facebook to follow ongoing coverage of Michigan State news, notes and opinion. You can also follow Cory Linsner on X @Cory_Linsner This article originally appeared on Spartans Wire: Michigan State football loses member of recruiting staff
Yahoo
5 minutes ago
- Yahoo
Jacob Soboroff To Join MSNBC As It Builds News Division In Advance Of Comcast Split
Jacob Soboroff will be part of the MSNBC team as it splits from Comcast and sister network NBC News later this year. Soboroff will serve as senior national and political correspondent for the network. More from Deadline Charlamagne Tha God Responds To Trump, Calls Out His "Authoritarian Strategy," But Adds, "I'm Rooting For You, But I Need You Focused" Senate Confirms Jeanine Pirro To Serve As U.S. Attorney For D.C. In Reaction To Dismal Jobs Report, Donald Trump Says He's Ordered Commissioner Of Labor Statistics To Be Fired As NBC News political and national correspondent, Soboroff has covered presidential campaigns and elections, the family separation crisis of 2018, and appeared as a correspondent and fill-in anchor on Today. He covered the Los Angeles wildfires earlier this year, with personal accounts of its impact on his hometown. The fires will be the subject of an upcoming book, Firestorm, to be published on Jan. 6. Soboroff also has been reporting on the ICE raids in Los Angeles, building on his experience covering immigration. He wrote the book Separated: Inside an American Tragedy, and was executive producer of Errol Morris' documentary Separated, based on his work. Soboroff first joined MSNBC in 2015. He'll be part of the network's live event, MSNBCLIVE '25, on Oct. 11. MSNBC will be part of Versant, the newly named comoany that will include former Comcast cable channels and other assets. With NBC News no longer as a sister network, MSNBC has been building up its own news division. Best of Deadline 2025 TV Cancellations: Photo Gallery 2025 TV Series Renewals: Photo Gallery 2025-26 Awards Season Calendar: Dates For Emmys, Oscars, Grammys & More